BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 36424471)

  • 1. Extracellular vesicles derived from cancer-associated fibroblasts carry tumor-promotive microRNA-1228-3p to enhance the resistance of hepatocellular carcinoma cells to sorafenib.
    Zhang Y; Pan Q; Shao Z
    Hum Cell; 2023 Jan; 36(1):296-311. PubMed ID: 36424471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-associated fibroblasts promote hepatocellular carcinoma progression through downregulation of exosomal miR-150-3p.
    Yugawa K; Yoshizumi T; Mano Y; Itoh S; Harada N; Ikegami T; Kohashi K; Oda Y; Mori M
    Eur J Surg Oncol; 2021 Feb; 47(2):384-393. PubMed ID: 32883551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LXR activation potentiates sorafenib sensitivity in HCC by activating microRNA-378a transcription.
    Lin Z; Xia S; Liang Y; Ji L; Pan Y; Jiang S; Wan Z; Tao L; Chen J; Lin C; Liang X; Xu J; Cai X
    Theranostics; 2020; 10(19):8834-8850. PubMed ID: 32754282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomal miR-93 derived from hepatocellular carcinoma cell promotes the sorafenib resistance of hepatocellular carcinoma through PTEN/PI3K/Akt pathway.
    Bao Y; Xu S; Zhou J; Zhao C; Dai S; Zhang Y; Rao M
    J Biochem Mol Toxicol; 2024 Mar; 38(3):e23666. PubMed ID: 38375688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of exosomal miR-320a from cancer-associated fibroblasts contributes to HCC proliferation and metastasis.
    Zhang Z; Li X; Sun W; Yue S; Yang J; Li J; Ma B; Wang J; Yang X; Pu M; Ruan B; Zhao G; Huang Q; Wang L; Tao K; Dou K
    Cancer Lett; 2017 Jul; 397():33-42. PubMed ID: 28288874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiRNA-124-3p.1 sensitizes hepatocellular carcinoma cells to sorafenib by regulating FOXO3a by targeting AKT2 and SIRT1.
    Dong ZB; Wu HM; He YC; Huang ZT; Weng YH; Li H; Liang C; Yu WM; Chen W
    Cell Death Dis; 2022 Jan; 13(1):35. PubMed ID: 35013144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrantly Expressed MicroRNAs in Cancer-Associated Fibroblasts and Their Target Oncogenic Signatures in Hepatocellular Carcinoma.
    Eun JW; Ahn HR; Baek GO; Yoon MG; Son JA; Weon JH; Yoon JH; Kim HS; Han JE; Kim SS; Cheong JY; Kim BW; Cho HJ
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular vesicle-encapsulated microRNA-296-3p from cancer-associated fibroblasts promotes ovarian cancer development through regulation of the PTEN/AKT and SOCS6/STAT3 pathways.
    Sun L; Ke M; Yin M; Zeng Y; Ji Y; Hu Y; Fu S; Zhang C
    Cancer Sci; 2024 Jan; 115(1):155-169. PubMed ID: 37972389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer-associated fibroblasts induce sorafenib resistance of hepatocellular carcinoma cells through CXCL12/FOLR1.
    Zhao J; Lin E; Bai Z; Jia Y; Wang B; Dai Y; Zhuo W; Zeng G; Liu X; Cai C; Li P; Zou B; Li J
    BMC Cancer; 2023 Dec; 23(1):1198. PubMed ID: 38057830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNA-19a-3p promotes tumor metastasis and chemoresistance through the PTEN/Akt pathway in hepatocellular carcinoma.
    Jiang XM; Yu XN; Liu TT; Zhu HR; Shi X; Bilegsaikhan E; Guo HY; Song GQ; Weng SQ; Huang XX; Dong L; Janssen HLA; Shen XZ; Zhu JM
    Biomed Pharmacother; 2018 Sep; 105():1147-1154. PubMed ID: 30021351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LINC01915 Facilitates the Conversion of Normal Fibroblasts into Cancer-Associated Fibroblasts Induced by Colorectal Cancer-Derived Extracellular Vesicles through the miR-92a-3p/KLF4/CH25H Axis.
    Zhou M; Wang S; Liu D; Zhou J
    ACS Biomater Sci Eng; 2021 Nov; 7(11):5255-5268. PubMed ID: 34643375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-128-3p overexpression sensitizes hepatocellular carcinoma cells to sorafenib induced apoptosis through regulating DJ-1.
    Guo XL; Wang HB; Yong JK; Zhong J; Li QH
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6667-6677. PubMed ID: 30402839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
    Gao J; Dai C; Yu X; Yin XB; Zhou F
    J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevating microRNA-1-3p shuttled by cancer-associated fibroblasts-derived extracellular vesicles suppresses breast cancer progression and metastasis by inhibiting GLIS1.
    Tao S; Li H; Ma X; Ma Y; He J; Gao Y; Li J
    Cancer Gene Ther; 2021 Jun; 28(6):634-648. PubMed ID: 33154575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone mesenchymal stem cells derived extracellular vesicles promote TRAIL-related apoptosis of hepatocellular carcinoma cells via the delivery of microRNA-20a-3p.
    Deng L; Wang C; He C; Chen L
    Cancer Biomark; 2021; 30(2):223-235. PubMed ID: 33136092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor cells derived-extracellular vesicles transfer miR-3129 to promote hepatocellular carcinoma metastasis by targeting TXNIP.
    Yang Y; Mao F; Guo L; Shi J; Wu M; Cheng S; Guo W
    Dig Liver Dis; 2021 Apr; 53(4):474-485. PubMed ID: 33563583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PU.1/microRNA-142-3p targets ATG5/ATG16L1 to inactivate autophagy and sensitize hepatocellular carcinoma cells to sorafenib.
    Zhang K; Chen J; Zhou H; Chen Y; Zhi Y; Zhang B; Chen L; Chu X; Wang R; Zhang C
    Cell Death Dis; 2018 Feb; 9(3):312. PubMed ID: 29472524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of AURKA/miR-199b-3p in hepatocellular carcinoma cells.
    Li G; Tian Y; Gao Z
    J Clin Lab Anal; 2022 Dec; 36(12):e24758. PubMed ID: 36377304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-126-3p suppresses tumor metastasis and angiogenesis of hepatocellular carcinoma by targeting LRP6 and PIK3R2.
    Du C; Lv Z; Cao L; Ding C; Gyabaah OA; Xie H; Zhou L; Wu J; Zheng S
    J Transl Med; 2014 Sep; 12():259. PubMed ID: 25240815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
    Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
    Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.